3-Quinolinecarboxamide, 4-[(3,4-dimethylphenyl)amino]-7-(4-pyridinyl)- |
CFMS RECEPTOR INHIBITOR II |
959860-85-6 |
N-[2-Methyl-4-[2-(2-methylphenyl)diazenyl]phenyl]-2-furancarboxamide |
N-[2-Methyl-4-[2-(2-methylphenyl)diazenyl]phenyl]-2-furancarboxamide |
289494-16-2 |
HIS-SER-ASP-ALA-VAL-PHE-THR-ASP-ASN-TYR-THR-ARG |
HIS-SER-ASP-ALA-VAL-PHE-THR-ASP-ASN-TYR-THR-ARG |
120928-03-2 |
ANOREXIGENIC PEPTIDE |
PYR-HIS-GLY |
69275-10-1 |
ANTIBIOTIC UCN-02 |
UCN-02 |
121569-61-7 |
AC-ILE-TYR-GLY-GLU-PHE-NH2 |
AC-ILE-TYR-GLY-GLU-PHE-NH2 |
168781-78-0 |
AKTIDE-2T |
ALA-ARG-LYS-ARG-GLU-ARG-THR-TYR-SER-PHE-GLY-HIS-HIS-ALA |
324029-01-8 |
AC-LEU-ARG-HIS-TYR-LEU-ASN-LEU-LEU-THR-ARG-GLN-ARG-TYR-NH2 |
AC-LEU-ARG-HIS-TYR-LEU-ASN-LEU-LEU-THR-ARG-GLN-ARG-TYR-NH2 |
155709-24-3 |
AEG 3482 |
6-苯基咪唑并[2,1-B]-1,3,4-噻二唑-2-磺酰胺 |
63735-71-7 |
ANTI-INFLAMMATORY PEPTIDE 2 |
HIS-ASP-MET-ASN-LYS-VAL-LEU-ASP-LEU |
118850-72-9 |
AF 1 |
LYS-ASN-GLU-PHE-ILE-ARG-PHE- NH2 |
130092-56-7 |
(ALA11,D-LEU15)-OREXIN B (HUMAN) |
ARG-SER-GLY-PRO-PRO-GLY-LEU-GLN-GLY-ARG-ALA-GLN-ARG-LEU-D-LEU-GLN-ALA-SER-GLY-ASN-HIS-ALA-ALA-GLY-ILE-LEU-THR-MET-NH2 |
532932-99-3 |
N6-[(4-nitrophenyl)methyl]-N2-[[3-(trifluoromethyl)phenyl]methyl]-1H-Purine-2,6-diamine |
TNP |
519178-28-0 |
AMINE:OXYGEN OXIDOREDUCTASE [DEAMINATING] |
等离子体胺氧化酶 |
9001-66-5 |
AMINO[(3,4-DICHLOROBENZYL)SULFANYL]METHANIMINIUM CHLORIDE |
AMINO[(3,4-DICHLOROBENZYL)SULFANYL]METHANIMINIUM CHLORIDE |
22816-60-0 |
ACPA |
ACPA |
229021-64-1 |
ANGIOGENIN (108-122) |
GLU-ASN-GLY-LEU-PRO-VAL-HIS-LEU-ASP-GLN-SER-ILE-PHE-ARG-ARG |
112173-49-6 |
A-VI-5 |
A-VI-5 |
39194-96-2 |
ALPHA-CONOTOXIN GI |
芋螺毒素 G I |
76862-65-2 |
ALPHA-CONOTOXIN IMI |
GLY-CYS-CYS-SER-ASP-PRO-ARG-CYS-ALA-TRP-ARG-CYS-NH2 |
156467-85-5 |